Atypical and typical antipsychotic drug interactions with the dopamine D2 receptor

被引:34
|
作者
Hjerde, E [1 ]
Dahl, SG [1 ]
Sylte, I [1 ]
机构
[1] Univ Tromso, Inst Med Biol, Dept Pharmacol, N-9037 Tromso, Norway
关键词
typical and atypical antipsychotics; dopamine D2 receptor; molecular dynamics; Ligand induced receptor conformation;
D O I
10.1016/j.ejmech.2004.10.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A model of the dopamine D2 receptor was used to study the receptor interactions of dopamine, the typical antipsychotics haloperidol and loxapine, and the atypical antipsychotics clozapine and melperone. The atypical antipsychotics interacted with the halogen atom of the ring system in the direction of the transmembrane helices (TMHs) 2, 3 and 7, while the typical had the corresponding halogen atom in the direction of TMH5. Molecular dynamics simulations indicated that the average helical displacement upon binding increased in the order: typical < atypical < dopamine. Upon binding, the atypical induced larger displacements into TMH5 than did the typical. The typical had stronger non-bonded interactions with the receptor than had the atypical, which is in agreement with the experimental observation that the atypical antipsychotic drugs dissociate faster from the receptor than the typical antipsychotic drugs. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 50 条
  • [1] Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
    Sheng Wang
    Tao Che
    Anat Levit
    Brian K. Shoichet
    Daniel Wacker
    Bryan L. Roth
    Nature, 2018, 555 : 269 - 273
  • [2] Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone
    Wang, Sheng
    Che, Tao
    Levit, Anat
    Shoichet, Brian K.
    Wacker, Daniel
    Roth, Bryan L.
    NATURE, 2018, 555 (7695) : 269 - +
  • [3] Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist
    Nadal, R
    CNS DRUG REVIEWS, 2001, 7 (03): : 265 - 282
  • [4] Interactions of the novel antipsychotic, aripiprazole, at the D2 dopamine receptor.
    Prioleau, C
    Lawler, CP
    Mailman, RB
    FASEB JOURNAL, 1998, 12 (04): : A456 - A456
  • [5] Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
    Im, Dohyun
    Inoue, Asuka
    Fujiwara, Takaaki
    Nakane, Takanori
    Yamanaka, Yasuaki
    Uemura, Tomoko
    Mori, Chihiro
    Shiimura, Yuki
    Kimura, Kanako Terakado
    Asada, Hidetsugu
    Nomura, Norimichi
    Tanaka, Tomoyuki
    Yamashita, Ayumi
    Nango, Eriko
    Tono, Kensuke
    Kadji, Francois Marie Ngako
    Aoki, Junken
    Iwata, So
    Shimamura, Tatsuro
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [6] Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone
    Dohyun Im
    Asuka Inoue
    Takaaki Fujiwara
    Takanori Nakane
    Yasuaki Yamanaka
    Tomoko Uemura
    Chihiro Mori
    Yuki Shiimura
    Kanako Terakado Kimura
    Hidetsugu Asada
    Norimichi Nomura
    Tomoyuki Tanaka
    Ayumi Yamashita
    Eriko Nango
    Kensuke Tono
    Francois Marie Ngako Kadji
    Junken Aoki
    So Iwata
    Tatsuro Shimamura
    Nature Communications, 11
  • [7] Typical and atypical antipsychotics:: Affinity and occupancy at the striatal dopamine D2 receptor and transporter
    Schmitt, GJE
    Meisenzahl, EM
    Frodl, T
    Dresel, S
    la Fougère, C
    Hahn, K
    Möller, HJ
    EUROPEAN PSYCHIATRY, 2004, 19 : 70S - 70S
  • [8] Atomistic molecular dynamics simulations of typical and atypical antipsychotic drugs at the dopamine D2 receptor (D2R) elucidates their inhibition mechanism
    Salmas, Ramin Ekhteiari
    Yurtsever, Mine
    Durdagi, Serdar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2017, 35 (04): : 738 - 754
  • [9] Converting a typical antipsychotic into an atypical one - The critical role of D2
    VanderSpek, SC
    Brownlee, BA
    Nobrega, J
    McClelland, R
    Seeman, R
    Kapur, S
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 117 - 118
  • [10] Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor
    Sahlholm, Kristoffer
    Marcellino, Daniel
    Nilsson, Johanna
    Ogren, Sven Ove
    Fuxe, Kjell
    Arhem, Peter
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (01): : 149 - 155